|
Canada-0-GINSENG ไดเรกทอรีที่ บริษัท
|
ข่าว บริษัท :
- Drugs - World Health Organization (WHO)
The use of psychoactive drugs without medical supervision is associated with significant health risks and can lead to the development of drug use disorders Drug use disorders, particularly when untreated, increase morbidity and mortality risks for individuals, can trigger substantial suffering and lead to impairment in personal, family, social, educational, occupational or other important
- WHO Drug Information
About WHO Drug Information WHO Drug Information is a quarterly journal providing an overview of topics relating to medicines development and regulation which is targeted to a wide audience of health professionals and policy makers Launched in 1987, WHO Drug Information communicates the latest international news and trends to regulatory agencies, academic and training institutions, researchers
- 基本药物 - World Health Organization (WHO)
基本药物是有效安全地满足人民医疗保健需求的药物。世卫组织根据公共卫生相关性、有关益处和危害的证据并考虑成本、负担能力和其他相关因素来选择基本药物。
- Alcohol, Drugs and Addictive Behaviours
Alcohol, Drugs and Addictive Behaviours The Unit works globally to improve health and well-being of populations by articulating, promoting, supporting and monitoring evidence-informed policies, strategies and interventions to reduce the burden associated with alcohol, drugs and addictive behaviours
- WHO Model Lists of Essential Medicines
The WHO Model Lists of Essential Medicines are updated every two years by the Expert Committee on Selection and Use of Essential Medicines The first Essential Medicines List was published in 1977, and the first Essential Medicines List for Children was published in 2007 The current versions, updated in September 2025, are the 24th Essential Medicines List (EML) and the 10th Essential
- Drugs (psychoactive) - World Health Organization (WHO)
Substitution maintenance therapy with methadone or buprenorphine improves the health and social performance of opioid-dependent people and decreases the use of illicit drugs and the crime rate Statistics show that investment in prevention pays off well: every dollar invested in drug treatment saves seven dollars in health and social costs
- Antifungal agents in clinical and preclinical development: overview and . . .
This report presents the first World Health Organization (WHO) analysis of antifungal agents in preclinical and clinical development It covers systemic antifungal drugs in development worldwide, including label extension and repurposed products, and critically evaluates how well the current pipeline addresses infections caused by WHO fungal priority pathogens
- 1. 3 Drug-resistant TB - World Health Organization (WHO)
1 3 Drug-resistant TB Since 1994, the World Health Organization (WHO) has systematically collected and analysed data on levels of resistance to anti-TB drugs from countries and areas (1)
- WHO and UNODC release landmark report on contaminated medicines, urging . . .
The World Health Organization (WHO) and the United Nations Office on Drugs and Crime (UNODC) have jointly released a landmark report unveiling critical findings on the persistent and preventable threat of contaminated medicines which claimed the lives and compromised the health of countless patients, predominantly children, through the ingestion of medicines with dangerously high levels of
|
|